Portland, OR, April 30, 2019 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Sanger’s Sequencing Service Market was valued at $368.22 million in 2017 and is expected to reach $1,085.17 million by 2025, registering the CAGR of 14.2% during the period 2018-2025. The report provides comprehensive analyses of the top winning strategies, industry dynamics, market size & estimations, key market segments, and competitive landscape.
Request Report Sample at: https://www.alliedmarketresearch.com/request-sample/4611
Factors such as technological advancements in Sanger's sequencing, surge in applications of Sanger's sequencing, and an increase in genome mapping programs have boosted the growth of the global sanger’s sequencing service market. However, lack of skilled professionals and standardization concerns over sequencing-based diagnostics act as impediments for the market growth. On the other hand, cloud computing serves as a potential data management service and lucrative opportunities in the emerging markets are likely to create lucrative opportunities for the market growth.
Among applications, the biomarker & cancer segment contributed more than one-third of the market share in 2017 and is likely to dominate the market through 2025. Nonetheless, the personalized medicine segment is likely to manifest the fastest CAGR of 16.1% from 2018 to 2025.
Among end users, the academic & government research institutes segment garnered 30.4% of the market share in 2017 and is expected to dominate the market during the forecast period. Nonetheless, the biotechnology companies segment is expected to grow at the fastest CAGR of 14.9% through 2025.
Among regions, the market in the U.S. held the largest share of more than two-fifths in 2017and would dominate the market through the study period. However, the market in China is also likely to register the fastest CAGR of 17.2% during the study period. Other regions analyzed in the study include EU, Japan, India, Southeast Asia, and ROW.
Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4611
A detailed analysis of the major players in the Sanger’s sequencing service market is offered in the report. The players listed include Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt. Limited, and Microsynth AG. Inc.
About Us:
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.